Table 2.
Clinical characteristics and comorbidities of COVID-19 patients admitted to Hiwot Fana specialized university hospital treatment center, Eastern Ethiopia
| Variables | Frequency (%) |
|---|---|
| COVI-19 clinical stage | |
| Critical | 86 (24.29) |
| Not critical | 268 (75.71) |
| Medication history | |
| Yes | 173 (48.73) |
| No | 182 (51.27) |
| Cough | |
| Yes | 279 (78.59) |
| No | 76 (21.41) |
| Fever | |
| Yes | 258 (72.68) |
| No | 97 (27.32) |
| Shortness of breath | |
| Yes | 112 (31.55) |
| No | 243 (68.45) |
| Hypertensive | |
| Yes | 83 (23.38) |
| No | 272 (76.62) |
| Diabetic | |
| Yes | 92 (25.92) |
| No | 263 (74.08) |
| Cardio vascular disease | |
| Yes | 68 (19.15) |
| No | 287 (80.85) |
| Renal disease | |
| Yes | 24 (6.76) |
| No | 331 (93.24) |
| Receiving dexamethasone | |
| Yes | 64 (18.03) |
| No | 291 (81.97) |
| Covid-19 outcome | |
| Discharged | 259 (72.96) |
| Death | 96 (27.04) |
| Partial oxygen saturation(mmHg) | 81.10 (SD ± 16.63) |
| Respiratory rate (breath/minute) | 31.41 (SD ± 10.29) |
| Heart rate (bpm) | 100.52 (SD ± 20.31) |
| Serum creatinine (mmol/L) | 1.32 (SD ± 1.46) |
| Lymphocyte count (1000/µL) | 18.05 (SD ± 14.27) |